1-20 of 355
Zeev Estrov
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Achieving complete remission in CLL patients treated with ibrutinib: clinical significance and predictive factors

Clinical Trials & Observations
Paolo Strati, Ellen J. Schlette, Luisa M. Solis Soto, Daniela E. Duenas, Mariela Sivina, Ekaterina Kim, Michael J. Keating, William G. Wierda, Alessandra Ferrajoli, Hagop Kantarjian, Zeev Estrov, Nitin Jain, Philip A. Thompson, Ignacio I. Wistuba, Jan A. Burger
Journal: Blood
Blood (2020) 135 (7): 510–513.
DOI: https://doi.org/10.1182/blood.2019003570
Published: 2020
Journal Articles

Minimal residual disease undetectable by next-generation sequencing predicts improved outcome in CLL after chemoimmunotherapy

Clinical Trials & Observations
Philip A. Thompson, Jaya Srivastava, Christine Peterson, Paolo Strati, Jeffrey L. Jorgensen, Tyler Hether, Michael J. Keating, Susan M. O’Brien, Alessandra Ferrajoli, Jan A. Burger, Zeev Estrov, Nitin Jain, William G. Wierda
Journal: Blood
Blood (2019) 134 (22): 1951–1959.
DOI: https://doi.org/10.1182/blood.2019001077
Published: 2019
Includes: Supplemental data
Journal Articles

Myelofibrosis osteoclasts are clonal and functionally impaired

Brief Report
Ivo Veletic, Taghi Manshouri, Asha S. Multani, C. Cameron Yin, Lei Chen, Srdan Verstovsek, Zeev Estrov
Journal: Blood
Blood (2019) 133 (21): 2320–2324.
DOI: https://doi.org/10.1182/blood-2018-10-878926
Published: 2019
Includes: Supplemental data
Journal Articles

Randomized trial of ibrutinib vs ibrutinib plus rituximab in patients with chronic lymphocytic leukemia

Clinical Trials & Observations
Jan A. Burger, Mariela Sivina, Nitin Jain, Ekaterina Kim, Tapan Kadia, Zeev Estrov, Graciela M. Nogueras-Gonzalez, Xuelin Huang, Jeffrey Jorgensen, Jianling Li, Mei Cheng, Fong Clow, Maro Ohanian, Michael Andreeff, Thomas Mathew, Philip Thompson, Hagop Kantarjian, Susan O’Brien, William G. Wierda, Alessandra Ferrajoli, Michael J. Keating
Journal: Blood
Blood (2019) 133 (10): 1011–1019.
DOI: https://doi.org/10.1182/blood-2018-10-879429
Published: 2019
Includes: Supplemental data
Journal Articles

A phase 2 study of ruxolitinib in combination with azacitidine in patients with myelofibrosis

Clinical Trials & Observations
Lucia Masarova, Srdan Verstovsek, Juliana E. Hidalgo-Lopez, Naveen Pemmaraju, Prithviraj Bose, Zeev Estrov, Elias J. Jabbour, Farhad Ravandi-Kashani, Koichi Takahashi, Jorge E. Cortes, Jing Ning, Maro Ohanian, Yesid Alvarado, Lingsha Zhou, Sherry Pierce, Romany Gergis, Keyur P. Patel, Rajyalakshmi Luthra, Tapan M. Kadia, Courtney D. DiNardo, Gautam Borthakur, Kapil Bhalla, Guillermo Garcia-Manero, Carlos E. Bueso-Ramos, Hagop M. Kantarjian, Naval Daver
Journal: Blood
Blood (2018) 132 (16): 1664–1674.
DOI: https://doi.org/10.1182/blood-2018-04-846626
Published: 2018
Includes: Supplemental data
Journal Articles

Clinical implications of cancer gene mutations in patients with chronic lymphocytic leukemia treated with lenalidomide

Clinical Trials & Observations
Koichi Takahashi, Boyu Hu, Feng Wang, Yuanqing Yan, Ekaterina Kim, Candida Vitale, Keyur P. Patel, Paolo Strati, Curtis Gumbs, Latasha Little, Samantha Tippen, Xingzhi Song, Jianhua Zhang, Nitin Jain, Philip Thompson, Guillermo Garcia-Manero, Hagop Kantarjian, Zeev Estrov, Kim-Anh Do, Michael Keating, Jan A. Burger, William G. Wierda, P. Andrew Futreal, Alessandra Ferrajoli
Journal: Blood
Blood (2018) 131 (16): 1820–1832.
DOI: https://doi.org/10.1182/blood-2017-11-817296
Published: 2018
Includes: Supplemental data
Journal Articles

A Phase I/II Study of Inotuzumab Ozogamicin in Combination with Low-Intensity Chemotherapy (mini-hyper-CVD) for Older Patients with Newly Diagnosed Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia

Nicholas J Short, MD, Hagop M. Kantarjian, MD, Farhad Ravandi, MBBS, Xuelin Huang, PhD, Nitin Jain, MD, Naval Daver, MD, Deborah A Thomas, MD, Naveen Pemmaraju, MD, Rita Khouri, Joseph David Khoury, MD, Jeffrey L. Jorgensen, MD PhD, Yesid Alvarado, MD, Koji Sasaki, MD, Marina Konopleva, MD PhD, Guillermo Garcia-Manero, MD, Tapan Kadia, MD, Jorge E. Cortes, MD, Christopher B Benton, MD, Gautam Borthakur, MD, Jan A. Burger, MD PhD, Maro Ohanian, DO, William G Wierda, MD PhD, Zeev Estrov, MD, Steven Kornblau, MD, Courtney D. DiNardo, MDMSc, Alessandra Ferrajoli, MD, Jovitta Jacob, RN, Ameena Manzoor, Rebecca Garris, Msc, Susan M. O'Brien, MD, Elias J. Jabbour, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2576.
DOI: https://doi.org/10.1182/blood.V130.Suppl_1.2576.2576
Published: 2017
Journal Articles

A Randomized Phase II Trial of 5-Day Versus 10-Day Schedules of Decitabine for Older Patients with Previously Untreated Acute Myeloid Leukemia

Nicholas J Short, MD, Hagop M. Kantarjian, MD, Guillermo Garcia-Manero, MD, Gautam Borthakur, MD, Tapan Kadia, MD, Xuelin Huang, PhD, Naval Daver, MD, Courtney D. DiNardo, MDMSc, Alessandra Ferrajoli, MD, William G Wierda, MD PhD, Zeev Estrov, MD, Christopher B Benton, MD, Prithviraj Bose, MD, Yesid Alvarado, MD, Steven Kornblau, MD, Maro Ohanian, DO, Yvonne Gaisor, Mary Ann Richie, Sherry Pierce, Elias J. Jabbour, MD, Jorge E. Cortes, MD, Farhad Ravandi, MBBS
Journal: Blood
Blood (2017) 130 (Supplement 1): 2577.
DOI: https://doi.org/10.1182/blood.V130.Suppl_1.2577.2577
Published: 2017
Journal Articles

The Prognostic Significance of Translocation (1;19) in Adult Patients (Pts) with B-Cell Acute Lymphoblastic Leukemia (ALL)

Musa Yilmaz, MD, Devendra KC, MD, Mary Abisola Akosile, PhD, Joseph David Khoury, MD, Nicholas J Short, MD, Jorge E. Cortes, MD, Guillermo Garcia-Manero, MD, Farhad Ravandi, MBBS, Tapan Kadia, MD, Koji Sasaki, MD, Marina Konopleva, MD PhD, William G Wierda, MD PhD, Nitin Jain, MD, Srdan Verstovsek, MD PhD, Zeev Estrov, MD, Sherry Pierce, BSN, BA, Susan M. O'Brien, MD, Elias J. Jabbour, MD, Hagop M. Kantarjian, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2712.
DOI: https://doi.org/10.1182/blood.V130.Suppl_1.2712.2712
Published: 2017
Journal Articles

Long-Term Outcome of CML Patients Treated with Second-Generation Tyrosine Kinase Inhibitors in the Second Line: A Single Center Experience

Kamal Chamoun, MD, Hagop M. Kantarjian, MD, Mary Abisola Akosile, PhD, Rita Assi, MD, Farhad Ravandi, MBBS, Gautam Borthakur, MD, Guillermo Garcia-Manero, MD, Tapan Kadia, MD, Marina Konopleva, MD PhD, Zeev Estrov, MD, Courtney D. DiNardo, MDMSc, Naval Daver, MD, Naveen Pemmaraju, MD, Alessandra Ferrajoli, MD, Jan A. Burger, MD PhD, William Wierda, MD, Elias J. Jabbour, MD, Jorge E. Cortes, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1594.
DOI: https://doi.org/10.1182/blood.V130.Suppl_1.1594.1594
Published: 2017
Journal Articles

Sotatercept (ACE-011) Alone and in Combination with Ruxolitinib in Patients (pts) with Myeloproliferative Neoplasm (MPN)-Associated Myelofibrosis (MF) and Anemia

Prithviraj Bose, MD, Naval Daver, MD, Naveen Pemmaraju, MD, Elias J. Jabbour, MD, Zeev Estrov, MD, Allison Pike, RN, Julie Huynh-Lu, Physician Assistant, Madeleine Nguyen-Cao, Physician Assistant, Xuemei Wang, Lingsha Zhou, Sherry Pierce, BSN, BA, Hagop M. Kantarjian, MD, Srdan Verstovsek, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 255.
DOI: https://doi.org/10.1182/blood.V130.Suppl_1.255.255
Published: 2017
Journal Articles

Updated Results of the Phase II Trial of Inotuzumab Ozogamicin (INO) Combined with Mini-Hyper-CVD As Salvage Therapy for Relapsed/Refractory (R/R) B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Rita Assi, MD, Hagop M. Kantarjian, MD, Rita Khouri, Farhad Ravandi, MBBS, Partow Kebriaei, MD, Nicholas J Short, MD, Deborah A Thomas, MD, Guillermo Garcia-Manero, MD, Richard E Champlin, MD, Tapan Kadia, MD, Jorge E. Cortes, MD, Nitin Jain, MD, Marina Konopleva, MD PhD, Zeev Estrov, MD, Koichi Takahashi, MD, Koji Sasaki, MD, Jovitta Jacob, RN, Ameena Manzoor, Rebecca Garris, Msc, Susan M. O'Brien, MD, Elias J. Jabbour, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2597.
DOI: https://doi.org/10.1182/blood.V130.Suppl_1.2597.2597
Published: 2017
Journal Articles

Correlation of Mutational Profile and Response in Patients with Polycythemia Vera and Essential Thrombocythemia Treated with Pegylated Interferon Alfa 2a As Part of a Prospective Phase II Study

Lucia Masarova, MD, Keyur Patel, MD PhD, Saradhi Mallampathi, PhD, Yawa Dzifa Duose, PhD, Kate J Newberry, PhD, Jorge E. Cortes, MD, Zeev Estrov, MD, Hagop M. Kantarjian, MD, Raja Luthra, Srdan Verstovsek, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1640.
DOI: https://doi.org/10.1182/blood.V130.Suppl_1.1640.1640
Published: 2017
Journal Articles

CLL Cell-Derived Exosomes Promote Bone Marrow Fibrosis and Inhibit Normal Hematopoietic Colony Proliferation

Uri Rozovski, MD, David M. Harris, Ping Li, PhD, Zhiming Liu, Taghi Manshouri, Ivo Veletic, MD, Carlos Bueso-Ramos, MD PhD, Preetesh Jain, MBBS,MDDM,PhD, Srdan Verstovsek, MD PhD, Alessandra Ferrajoli, MD, Jan A. Burger, MD PhD, Prithviraj Bose, MD, Philip A Thompson, MBBS, Nitin Jain, MD, William G Wierda, MD PhD, Michael J. Keating, MD, Zeev Estrov, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1728.
DOI: https://doi.org/10.1182/blood.V130.Suppl_1.1728.1728
Published: 2017
Journal Articles

Interim Phase 2 Clinical Trial Results for LCL161, an Oral Smac Mimetic, in Patients with Intermediate or High Risk Myelofibrosis

Naveen Pemmaraju, MD, Bing Z Carter, PhD, Hagop M. Kantarjian, MD, Prithviraj Bose, MD, Tapan Kadia, MD, Elias J. Jabbour, MD, Courtney D. DiNardo, MDMSc, Naval Daver, MD, Zeev Estrov, MD, Jorge E. Cortes, MD, Guillermo Garcia-Manero, MD, Lingsha Zhou, Po Yee Mak, Karina Salinas, RN, Carla Kay Tuttle, RN, Sherry Pierce, BSN, BA, Uday Popat, MD, Srdan Verstovsek, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 256.
DOI: https://doi.org/10.1182/blood.V130.Suppl_1.256.256
Published: 2017
Journal Articles

Neoplastic Monocyte-Derived Osteoclasts Are Highly Proliferative, but Sub-Functional in MPN-Associated Myelofibrosis

Ivo Veletic, MD, Taghi Manshouri, C. Cameron Yin, MD PhD, Kate J Newberry, PhD, Srdan Verstovsek, MD PhD, Zeev Estrov, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1664.
DOI: https://doi.org/10.1182/blood.V130.Suppl_1.1664.1664
Published: 2017
Journal Articles

Evaluating the Role of Lower Dose Dasatinib in Newly Diagnosed Early Chronic Phase-Chronic Myeloid Leukemia (CML-CP)

Kiran Naqvi, MDMPH, Jorge E. Cortes, MD, Jeffrey Skinner, MHA, Elias J. Jabbour, MD, Naveen Pemmaraju, MD, Prithviraj Bose, MD, Philip A Thompson, MBBS, Gautam Borthakur, MD, Zeev Estrov, MD, Hagop M. Kantarjian, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1611.
DOI: https://doi.org/10.1182/blood.V130.Suppl_1.1611.1611
Published: 2017
Journal Articles

Dynamics of Measurable Disease at Remission Determines Survival in Patients (Pts) with Philadelphia Chromosome Negative B-Cell Acute Lymphoblastic Leukemia (ALL)

Musa Yilmaz, MD, Elias J. Jabbour, MD, Xuemei Wang, Sanam Loghavi, MD, Joseph David Khoury, MD, Jeffrey L. Jorgensen, MD PhD, Farhad Ravandi, MBBS, Nicholas J Short, MD, Jorge E. Cortes, MD, Guillermo Garcia-Manero, MD, Tapan Kadia, MD, Koji Sasaki, MD, Marina Konopleva, MD PhD, Koichi Takahashi, MD, Maria Khouri, Nitin Jain, MD, Srdan Verstovsek, MD PhD, Zeev Estrov, MD, Zeev Estrov, MD, Prithviraj Bose, MD, Sherry Pierce, BSN, BA, Rebecca Garris, Msc, Susan M. O'Brien, MD, Hagop M. Kantarjian, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1434.
DOI: https://doi.org/10.1182/blood.V130.Suppl_1.1434.1434
Published: 2017
Journal Articles

Prognostic Index for Survival in Adult Patients with Philadelphia-Negative B-Cell Acute Lymphoblastic Leukemia (ALL)

Musa Yilmaz, MD, Hagop M. Kantarjian, MD, Xuemei Wang, Devendra KC, MD, Joseph David Khoury, MD, Farhad Ravandi, MBBS, Nicholas J Short, MD, Jorge E. Cortes, MD, Guillermo Garcia-Manero, MD, Tapan Kadia, MD, Koji Sasaki, MD, Marina Konopleva, MD PhD, William G Wierda, MD PhD, Maria Khouri, Nitin Jain, MD, Srdan Verstovsek, MD PhD, Zeev Estrov, MD, Prithviraj Bose, MD, Sherry Pierce, BSN, BA, Rebecca Garris, Msc, Susan M. O'Brien, MD, Elias J. Jabbour, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1435.
DOI: https://doi.org/10.1182/blood.V130.Suppl_1.1435.1435
Published: 2017
Journal Articles

Sustained Long-Lasting Responses after Lenalidomide Discontinuation in Patients with Chronic Lymphocytic Leukemia

Paolo Strati, MD, Alessandra Ferrajoli, MD, William G Wierda, MD PhD, Nitin Jain, MD, Philip A Thompson, MBBS, Susan M. O'Brien, MD, Katy Rezvani, MD PhD, Hagop M. Kantarjian, MD, Jan A. Burger, MD PhD, Christina Hinojosa, Michael J. Keating, MD, Zeev Estrov, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3024.
DOI: https://doi.org/10.1182/blood.V130.Suppl_1.3024.3024
Published: 2017